POTASSIUM CHLORIDE
- Product NDC
- 71610-632
- 11-digit product format
- 716100632
- Labeler code
- 71610
- Product ID
- 71610-632_43fa1a49-9d48-17b2-e063-6394a90ac4f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Potassium Chloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA214422
- Marketing category
- ANDA
- Marketing start
- 2021-01-20
- Substance
- POTASSIUM CHLORIDE
- Active strength
- 1500 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- POTASSIUM CHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| POTASSIUM CHLORIDE | 1500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 660YQ98I10 |
| Rxcui | 1801294 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-632-15 | POTASSIUM CHLORIDE | 15 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 15 | | 3 |
| 71610-632-30 | POTASSIUM CHLORIDE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 3 |
| 71610-632-45 | POTASSIUM CHLORIDE | 45 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 45 | | 3 |
| 71610-632-53 | POTASSIUM CHLORIDE | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 3 |
| 71610-632-60 | POTASSIUM CHLORIDE | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | | 3 |
| 71610-632-70 | POTASSIUM CHLORIDE | 120 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 120 | | 3 |
| 71610-632-80 | POTASSIUM CHLORIDE | 180 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 180 | | 3 |
| 71610-632-92 | POTASSIUM CHLORIDE | 270 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 270 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-632 | POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Current NDC, Legacy NDC, 8 package rows | 20250424_61fe55c2-fc9a-4fae-899a-06601baa78e1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-632-15 | 71610063215 | 15 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-15) | 2022-02-04 | 0000-00-00 | No | No | Current |
| 71610-632-30 | 71610063230 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-30) | 2022-02-04 | 0000-00-00 | No | No | Current |
| 71610-632-45 | 71610063245 | 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-45) | 2022-02-04 | 0000-00-00 | No | No | Current |
| 71610-632-53 | 71610063253 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-53) | 2022-02-04 | 0000-00-00 | No | No | Current |
| 71610-632-60 | 71610063260 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-60) | 2022-02-04 | 0000-00-00 | No | No | Current |
| 71610-632-70 | 71610063270 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-70) | 2025-11-19 | | No | No | Historical |
| 71610-632-80 | 71610063280 | 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-80) | 2022-02-04 | 0000-00-00 | No | No | Current |
| 71610-632-92 | 71610063292 | 270 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-632-92) | 2025-04-21 | | No | No | Historical |